Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 1:00 AM ET

Date/Time Source News Release
06/05/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025
05/22/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase
05/21/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction
05/14/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations
05/12/2025 04:30 PM EDT GlobeNewswire Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
04/29/2025 09:05 AM EDT GlobeNewswire Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
04/24/2025 07:55 AM EDT GlobeNewswire Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025
04/16/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
04/09/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix's Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana's Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies
04/07/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
Page

Additional News

As of June 7, 2025 • 1:00 AM ET

Date/Time Source News Release
06/05/2025 09:37 AM EDT BioMedWire BioMedNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at EULAR 2025 in Barcelona 
05/30/2025 04:02 PM EDT SeekingAlpha Tonix Pharmaceuticals: August PDUFA Date For Fibromyalgia Med A Risky Bet
05/28/2025 09:50 AM EDT SeekingAlpha Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit
05/22/2025 09:15 AM EDT BioMedWire BioMedNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO Joins A.G.P. Healthcare Showcase Fireside Chat 
05/21/2025 12:31 PM EDT PRISM News Tonix Begins Phase 2 Study of TNX-102 SL for Acute Stress Reaction, Targeting PTSD Prevention
05/21/2025 09:35 AM EDT InvestorWire InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Doses First Patient in DoD-Backed OASIS Trial for Acute Stress Reaction
05/16/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: AI Infrastructure and Mental Health Fuel Market Gains
05/14/2025 09:45 AM EDT InvestorWire InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations
05/13/2025 09:43 AM EDT TechMediaWire TechMediaBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Prepares for Potential Fibromyalgia Drug Approval, Reports Q1 Results 
05/12/2025 05:19 PM EDT SeekingAlpha Tonix Pharmaceuticals GAAP EPS of -$2.84 beats by $0.39, revenue of $2.43M misses by $0.12M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.